These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 17029602

  • 1. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice.
    Girard BA, Lelievre V, Braas KM, Razinia T, Vizzard MA, Ioffe Y, El Meskini R, Ronnett GV, Waschek JA, May V.
    J Neurochem; 2006 Oct; 99(2):499-513. PubMed ID: 17029602
    [Abstract] [Full Text] [Related]

  • 2. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [Abstract] [Full Text] [Related]

  • 4. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M, Sakuragawa S, Tabuchi A, Tsuda M.
    J Neurosci Res; 2004 Jul 01; 77(1):26-34. PubMed ID: 15197736
    [Abstract] [Full Text] [Related]

  • 5. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis.
    Isobe K, Kaneko M, Kaneko S, Nissato S, Nanmoku T, Takekoshi K, Okuda Y, Kawakami Y.
    Regul Pept; 2004 Dec 15; 123(1-3):29-32. PubMed ID: 15518890
    [Abstract] [Full Text] [Related]

  • 6. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 15; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 7. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M.
    Regul Pept; 2004 Aug 15; 120(1-3):99-105. PubMed ID: 15177926
    [Abstract] [Full Text] [Related]

  • 8. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):745-52. PubMed ID: 15872042
    [Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug 15; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 10. The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus.
    Dragich JM, Loh DH, Wang LM, Vosko AM, Kudo T, Nakamura TJ, Odom IH, Tateyama S, Hagopian A, Waschek JA, Colwell CS.
    Eur J Neurosci; 2010 Mar 15; 31(5):864-75. PubMed ID: 20180841
    [Abstract] [Full Text] [Related]

  • 11. Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression.
    Pavelock KA, Girard BM, Schutz KC, Braas KM, May V.
    J Neurochem; 2007 Feb 15; 100(3):603-16. PubMed ID: 17181550
    [Abstract] [Full Text] [Related]

  • 12. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R.
    Mol Cell Neurosci; 2006 Feb 15; 31(2):193-209. PubMed ID: 16226889
    [Abstract] [Full Text] [Related]

  • 13. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic development.
    DiCicco-Bloom E, Deutsch PJ, Maltzman J, Zhang J, Pintar JE, Zheng J, Friedman WF, Zhou X, Zaremba T.
    Dev Biol; 2000 Mar 15; 219(2):197-213. PubMed ID: 10694416
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M, Gozes I.
    Regul Pept; 2004 Dec 15; 123(1-3):33-41. PubMed ID: 15518891
    [Abstract] [Full Text] [Related]

  • 15. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
    Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I.
    J Cell Physiol; 2009 Oct 15; 221(1):75-83. PubMed ID: 19496170
    [Abstract] [Full Text] [Related]

  • 16. PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.
    Cardoso JC, Vieira FA, Gomes AS, Power DM.
    Peptides; 2007 Sep 15; 28(9):1902-19. PubMed ID: 17826180
    [Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun 15; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 18. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells.
    Falktoft B, Georg B, Fahrenkrug J.
    Neuropeptides; 2009 Oct 15; 43(5):387-96. PubMed ID: 19712974
    [Abstract] [Full Text] [Related]

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Pol J Pharmacol; 2004 Oct 15; 56(2):203-11. PubMed ID: 15156071
    [Abstract] [Full Text] [Related]

  • 20. Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.
    Kalló I, Kalamatianos T, Piggins HD, Coen CW.
    J Neuroendocrinol; 2004 Sep 15; 16(9):758-66. PubMed ID: 15344914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.